Compound information
- Natural Products
- ZC2207528
- Molecular Formula
- C16H13F3N2O3S
- Molecular Weight
- 370.059897936 g/mol
- Structure
-
- IUPAC Name
- N-[4-[[3-(trifluoromethyl)phenyl]sulfamoyl]phenyl]prop-2-enamide
- InChI
- InChI=1S/C16H13F3N2O3S/c1-2-15(22)20-12-6-8-14(9-7-12)25(23,24)21-13-5-3-4-11(10-13)16(17,18)19/h2-10,21H,1H2,(H,20,22)
- InChI Key
- XGIWRQCTAAUTOQ-UHFFFAOYSA-N
- SMILES
- C=CC(=O)Nc1ccc(S(=O)(=O)Nc2cccc(C(F)(F)F)c2)cc1
- Source
- ZINC001875365069
Warheads
- Acrylamide
-
ADMET Property
Physicochemical Property
Property | Value | Property | Value |
---|---|---|---|
Heavy Atom Count | 25 | Ring Count | 2 |
Heteroatom Count | 9 | Rotatable Bond Count | 5 |
Hydrogen Bond Acceptor Count | 3 | Hydrogen Bond Donor Count | 2 |
Topological Polar Surface Area | 75.27 Å2 | LogP | 3.659 |
LogS | -4.665 | LogD | 2.453 |
Absorption
Property | Value | Property | Value |
---|---|---|---|
Pgp inhibitor | 0.065 | Pgp substrate | 0.73 |
HIA | 0.965 | F20 % | 0.991 |
F30 % | 0.977 | Caco-2 | -5.249 |
MDCK | -4.872 |
Distribution
Property | Value | Property | Value |
---|---|---|---|
BBB Penetration | 0.022 | PPB | 100.908 |
VD | 1.141 | Fu | 2.073 |
Metabolism
Property | Value | Property | Value |
---|---|---|---|
CYP1A2 inhibitor | 0.826 | CYP1A2 substrate | 0.663 |
CYP2A6 substrate | 0.645 | CYP2B6 substrate | 0.598 |
CYP2C19 inhibitor | 0.98 | CYP2C19 substrate | 0.919 |
CYP2C8 substrate | 0.731 | CYP2C9 inhibitor | 0.898 |
CYP2C9 substrate | 0.961 | CYP2D6 inhibitor | 0.7 |
CYP2D6 substrate | 0.948 | CYP2E1 substrate | 0.876 |
CYP3A4 inhibitor | 0.725 | CYP3A4 substrate | 0.946 |
Excretion
Property | Value | Property | Value |
---|---|---|---|
T1/2 | 0.107 | CL | 0.215 |
Toxicity
Property | Value | Property | Value |
---|---|---|---|
hERG Blockers | 0.003 | Hepatotoxicity | 1.0 |
Mutagenicity | 0.026 | Rat Oral Acute Toxicity | 0.119 |
FDAMDD | 0.297 | Skin Sensitization | 0.85 |
Carcinogenicity | 0.005 | Eye Corrosion | 0.003 |
Eye Irritation | 0.466 | Respiratory Toxicity | 0.007 |
Environmental Toxicity
Property | Value | Property | Value |
---|---|---|---|
Bioconcentration Factors | 0.601 | IGC50 | 4.297 |
LC50FM | 3.995 | LC50DM | 4.085 |
Tox21 Pathway
Property | Value | Property | Value |
---|---|---|---|
NR-AR | 0.212 | NR-AR-LBD | 0.27 |
NR-AhR | 0.058 | NR-Aromatase | 0.052 |
NR-ER | 0.411 | NR-ER-LBD | 0.32 |
NR-PPAR-gamma | 0.756 | SR-ARE | 0.732 |
SR-ATAD5 | 0.304 | SR-HSE | 0.033 |
SR-MMP | 0.912 | SR-p53 | 0.169 |
Similar covalent inhibitors
Similar covalent drugs
No similar covalent drugs found for this compound.